Top of the morning to you. A brisk and shiny day is unfolding here on the Pharmalot corporate campus, where we are scurrying to catch up after a series of meetings yesterday. To cope, we are brewing that mandatory cup of stimulation - our flavor today is Rain Forest Nut. And, of course, we are scanning the world for interesting items. Keep us in mind if you come across one yourself. Meanwhile, have a great day...
SurModics Cuts 9 Percent Of Jobs As CFO Leaves (Minneapolis Star-Tribune)
FDA Warns Of Heart Risk With High Dose Of Celexa (Associated Press)
Drug Rep Arrested For Stealing Oxycodone From Pharmacy (4029TV)
Brazil And USP Ink Deal To Harmonize Standards (InPharma Technologist)
Par Pharmaceuticals Buys Anchen For $410 Million (Reuters)
Sanofi Agrees To Buy Indian Nutriceutical Unit (Bloomberg News)
Repeated Hypertension Readings Are More Cost Effective: Study (Reuters)
Novo Nordisk VC Arm Helps Launch Sight-Loss Company (Pharma Times)
HPV Test May Better Predict Cervical Cancer Than Pap Smear (HealthDay)
EDITOR'S NOTE: Please check this post for updates throughout the morning
1 Comment
The drug rep incident may accelerate the trend of pharmacies not stocking oxycodone. Maybe we should create a dispensary system for narcotics like the old banks. Used to be no branch banks. You had to go to the one bank in town and wait your turn. Likewise put one narcotics dispensary in town, fortify it with bars and bulletproof glass, a camera surveillance system, and an armed gaurd in front with a large unfriendly German Shepherd. That will put a stop to all this business. Drug reps would not be permitted in the store but would be required to conduct their business in an adjacent area that has no access to the main pharmacy.